Drugs / 2,4-dichlorobenzyl alcohol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03944655 Comparator | Jan → Aug 2019 | pharyngitis | Dr Sebastian Sundaraj | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2,4-dichlorobenzyl alcohol | “Oral administration of a Strepsils® Max Plus lozenge containing the active ingredients amylmetacresol 0.6 mg, 2,4-dichlorobenzyl alcohol 1.2 mg, lignocaine hydrochloride 10mg...” NCT03944655 ↗ |
| Route | Oral | “Oral administration of a Strepsils® Max Plus lozenge” NCT03944655 ↗ |